Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
256 GBX | -1.54% | +21.19% | +18.44% |
Apr. 29 | FTSE 100 as investors look to Fed rate decision | AN |
Apr. 29 | Transcript : Oxford Biomedica plc, Q4 2023 Earnings Call, Apr 29, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.44% | 326M | |
-2.63% | 102B | |
+1.62% | 96.29B | |
+1.60% | 22.18B | |
-16.67% | 21.2B | |
-8.75% | 18.31B | |
-38.74% | 17.38B | |
-13.21% | 16.36B | |
+5.41% | 13.97B | |
+33.57% | 12.17B |
- Stock Market
- Equities
- OXB Stock
- News Oxford Biomedica plc
- Oxford Biomedica plc announced that it expects to receive £50.000001 million in funding